POLICYBZRNSEQ1 FY 2025-26August 07, 2025

PB Fintech Limited

12,435words
28turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
), Mumbai – 400051 BSE Limited Department of Corporate Services/ Listing Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400001 SYMBOL: POLICYBZR SCRIP CODE: 543390 Sub: Transcript of t
₹6,616
goes for the entire 23k of us. Thank you very much. Our total insurance premium this quarter was ₹6,616 Cr, up 36% YoY. This was led by growth in the core protection business, but specifically, Health, w
36%
ntire 23k of us. Thank you very much. Our total insurance premium this quarter was ₹6,616 Cr, up 36% YoY. This was led by growth in the core protection business, but specifically, Health, which grew
65%
. This was led by growth in the core protection business, but specifically, Health, which grew at 65%, which is one of the highest in the last 9 quarters. The core online insurance premium grew 35% wi
35%
at 65%, which is one of the highest in the last 9 quarters. The core online insurance premium grew 35% with 46% from Health and Term, which is the protection area. Our consolidated operating revenue gr
46%
hich is one of the highest in the last 9 quarters. The core online insurance premium grew 35% with 46% from Health and Term, which is the protection area. Our consolidated operating revenue grew at 33%
33%
46% from Health and Term, which is the protection area. Our consolidated operating revenue grew at 33% to ₹1,348 Cr for the quarter and core insurance was up 37% YoY. The core credit was down 22% year
₹1,348
m Health and Term, which is the protection area. Our consolidated operating revenue grew at 33% to ₹1,348 Cr for the quarter and core insurance was up 37% YoY. The core credit was down 22% year on year. O
37%
consolidated operating revenue grew at 33% to ₹1,348 Cr for the quarter and core insurance was up 37% YoY. The core credit was down 22% year on year. Our renewal and trail revenue of the last 12 month
22%
w at 33% to ₹1,348 Cr for the quarter and core insurance was up 37% YoY. The core credit was down 22% year on year. Our renewal and trail revenue of the last 12 month rolling basis is at ₹725 Cr up fr
₹725
was down 22% year on year. Our renewal and trail revenue of the last 12 month rolling basis is at ₹725 Cr up from ₹506 Cr last year, so about 43% YoY growth. This you're seeing at a very consistent rate
₹506
ar on year. Our renewal and trail revenue of the last 12 month rolling basis is at ₹725 Cr up from ₹506 Cr last year, so about 43% YoY growth. This you're seeing at a very consistent rate, moving at abou
Guidance — 20 items
Sachin Salgaonkar
opening
Yes, we will deliver profits, but they will be an outcome.
Sachin Salgaonkar
opening
There will be a point when we will perhaps optimize for profits.
Sachin Salgaonkar
opening
But that will be a natural course for a while.
Suresh Ganapathy
opening
I know you guys have also been realistic, you believe medium term we should grow twice the industry, may be closer to about 30%.
Suresh Ganapathy
opening
Management: That is a very fair way of thinking about it, and I wouldn't expect any outside person to think any differently but that is not how we have ever thought about.
Suresh Ganapathy
opening
I'm sure you have a market projection, let's say, of the next 10 years, for both Health and Term.
Suresh Ganapathy
opening
Whatever that market projection is, our belief is Policybazaar alone will be bigger than that market projection over the next 10 years.
Sanketh Godha
opening
Is it fair to say that your take rates, because you are chosen to take in a deferred way, will be better when you recognize on upfront basis on revenue?
Sanketh Godha
opening
I would say, look, if you want directionally, there's a likelihood that next year we should be very close to, numbers which have become meaningless from a profit or loss perspective both from a new initiatives perspective.
Sanketh Godha
opening
As I have always said we could end up being a bit counter cyclical in this, because we do want market share, and I don't think we will hold ourselves back for any short-term profit delivery target.
Advertisement
Risks & concerns — 15 flagged
And third I would say, is building a lot of alternate data sources to basically sharpen our risk ability.
Sachin Salgaonkar
I think the sharpness in risk and being able to qualify a customer better for credit that is the third area that you will see us do a lot of work in.
Sachin Salgaonkar
You will see us now doing collections, you're seeing us now doing bill payment, etc, a lot of that really builds up from a deep risk capability.
Sachin Salgaonkar
Wanted to understand are you guys seeing any competitive intensity and any impact of that which could be visible on the numbers?
Sachin Salgaonkar
It is becoming difficult to digest that you can even grow at 30% when the overall market growth is stunted to some extent.
Suresh Ganapathy
I think Suresh, it's a very difficult question to answer on an open forum.
Suresh Ganapathy
From a time when your ULIPs were discredited and there was a concern around cost structure, etc, to a point where they are now in the long run, actually better than mutual funds.
Suresh Ganapathy
But yes, it can deliver something, and I would say, let's see, we're not putting pressure on that but I would suspect, maybe something like a 5% should appear at some point but whether it happened by 2030 or 2029 or 2031, I don't know.
Sanketh Godha
For a lot of people, the concern is they want the upside of the market, but they also want to protect their capital that they are investing.
Shreya Shivani
Paisa right now has dual challenge as I see it.
Dipanjan Ghosh
So look there is going to be till September, a little bit of drag on cash flow from normal course.
Dipanjan Ghosh
Because if it's gone from now, maybe the quality of that wasn't as strong, and that is why we are facing a challenge.
Dipanjan Ghosh
I think over a period of time, we are part of the change that the industry is going towards, and the direction that the industry is going, and I think in that scenario we will get our fair share of what is what is due to us, and I don't, particularly at this point see that being a huge challenge.
Dipanjan Ghosh
Then definitely, what you're saying is right, that there will be pressure on everything.
Dipanjan Ghosh
It is not a simple solution, because on one side they are seeing price hikes; on another side, they are seeing stress on claims.
Dipanjan Ghosh
Speaking time
Sanketh Godha
8
Madhukar Ladha
7
Shreya Shivani
4
Sachin Salgaonkar
3
Suresh Ganapathy
3
Dipanjan Ghosh
3
Advertisement
Opening remarks
Sachin Salgaonkar
Thanks, Rasleen. Hope I'm audible. Thank you, Management. I have three questions. First question - want to understand again how is management thinking in terms of balancing between growth and profitability. Clearly, as Yashish indicated for last 7 quarters, we are seeing 40%+ growth in terms of core business. But when I look on a YoY basis, your core online EBITDA margin is largely flattish at 14%. Should we sort of look at this business that it's matured from a margin perspective and management is focusing in terms of growing at 30-40% odd percent plus going ahead. Or should we also continue to see a margin improvement plus the growth out here? So that's question one. Let me pause here and pass it on to you guys. Management: Q1 is actually fairly straightforward. Our focus for the time being is entirely on growth. Yes, we will deliver profits, but they will be an outcome. We are clearly not optimizing for profits right now. There will be a point when we will perhaps optimize for profi
Sachin Salgaonkar
Thank you. Last question. Of late, there appears to be some increase in competitive intensity from some of the smaller players and platforms in the new initiative space. Wanted to understand are you guys seeing any competitive intensity and any impact of that which could be visible on the numbers? Management: I think you may be speaking about the POSP platform, so I'll just defer to Sarbvir on that. Management: Sachin, I would say this has been a very competitive space all around. I don't see anything very dramatic that has changed over there. I think there's a whole bunch of people who've been competing and the basis of competition has to shift. We have to focus on more granular business and work with smaller partners and add value to them. I think that's the race. If you ask me honestly, it's no longer a competitive issue. It's issue of, can we add value to our agent partners, and how much so that we can all have better economics. Management: Sachin, I just wanted to add there, more
Sachin Salgaonkar
Very clear. Thank you guys and all the best. Management: Thank you, Sachin. We'll take the next question from Suresh Ganapathy, Macquarie. Suresh, please unmute yourself.
Suresh Ganapathy
Thanks, Rasleen. Just one main question is now that Health is done so well, and of course Term has always been doing well for you guys. What would be now your market share in these two products Yashish. If I were to take retail Health premiums overall in the industry, what would be PB Fintech's share, and also on the retail Term? Roughly, if you can state those numbers. Management: I'll try to but I'll state something else a little before that, because I've been thinking deeply about this. The year Policybazaar started, the total Health and Term business in the country for retail was about ₹200 Cr. If we thought market share at that time. Actually there was an investor that time, Suresh. I won't name them. But they said, “Listen, the total market is ₹200 Cr. If you guys are 30% of this market, that’s ₹60 Cr opportunity. Why should we invest ₹20 Cr behind a business like that and so they left it out.” Another investor did not know what the Health and Term market was, and so they did inv
Suresh Ganapathy
There's one last question on the Savings thing. I'll just squeeze in. So you are right now, 2% of the market but it's stuck around that for quite some time, right? And the growth has not been great here. I mean, that's an enormous opportunity, because 80-85% of the market is Savings business. What's wrong here, or what's getting stuck here as to why you're not able to do this at a faster rate? Management: Suresh, I'll just answer that question once, and then I'll hand over to Sarbvir. At IPO, we were point 0.4%, we're at 2% now. In these years, we have moved from 0.4% to 2%. I think Sarbvir is perhaps better placed at why we are at 2% and not at 15%, like Health, etc. Management: Thanks Yashish. I think Suresh, it's a very difficult question to answer on an open forum. I would say that you have to look at it from a relevant perspective. If you look at ULIPs, if you look at the better-quality products that are sold, I think our share is more meaningful, and we always believe and in line
Suresh Ganapathy
Thanks so much, Sarbvir. Management: Thank you, Suresh. We'll take the next question from Sanketh Godha, Avendus Spark. Sanketh, please unmute yourself.
Advertisement
← All transcriptsPOLICYBZR stock page →